Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

@article{Heres2006WhyOB,
  title={Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.},
  author={S. Heres and J. Davis and K. Maino and E. Jetzinger and Werner Kissling and S. Leucht},
  journal={The American journal of psychiatry},
  year={2006},
  volume={163 2},
  pages={
          185-94
        }
}
  • S. Heres, J. Davis, +3 authors S. Leucht
  • Published 2006
  • Medicine, Psychology
  • The American journal of psychiatry
  • OBJECTIVE In many parts of the world, second-generation antipsychotics have largely replaced typical antipsychotics as the treatment of choice for schizophrenia. Consequently, trials comparing two drugs of this class--so-called head-to-head studies--are gaining in relevance. The authors reviewed results of head-to-head studies of second-generation antipsychotics funded by pharmaceutical companies to determine if a relationship existed between the sponsor of the trial and the drug favored in the… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 87 REFERENCES